Ticketcorner and Starticket unite to fight together against the big international competition. The merger agreements were signed in Zurich today by the directions of Ticketcorner Holding and Tamedia, specify the transaction partners in a statement.
The German chemical group BASF will cut 180 jobs in the Basel region: the cut will occur within 2018 and will cover the area of research and development. The measure is part of a restructuring launched worldwide.
In the research center in Basel – with offices in Basel and Schweizerhalle-Rosental – BASF works with additives and pigments for plastics and lacquers, as well as new materials for organic electronics and 3D printing. Most of these activities will be halted or moved elsewhere in the group, it said in a statement. The Basel region will remain important, however, for other research and development activities, emphasizes the group. In addition to the 180 jobs eliminated there will be an additional 100 to be transferred to other business units in Switzerland.
Deutsche Bank reported a profit of €278m in Q3, which compares favorably to a 6 billion euro loss for the same period a year ago, beating analysts’ average expectations that it would make a net loss of around €610 million.
Deutsche Bank said the "tough interest rate environment" and "unsettling effect" of negotiations with US authorities had been felt.
Twitter may soon cut 8% of its workforce, or about 300 people, Bloomberg reported Monday citing people it said were familiar with the matter. A company spokeswoman declined to comment.
Last year, Twitter announced, more or less, the same plan, or to axe 336 employees, about 8%, a week after Jack Dorsey, its co-founder who had been serving as interim chief executive, took over as permanent CEO.
The Post continues the reduction of their traditional offices: from the existing 1,400 today, it will come down to a number between 800 and 900 by 2020. In a statement today, the yellow giant announced that 1,200 employees "may be affected by a change". There were however no planned layoffs.
Over the next four years, the company intends to continue the development of the network access points, taking them from the current 3,700 to at least 4,000. If possible, it will continue to focus on the format tested by years of agency or branch with partners.
Apple posted a quarterly revenue of $46.9 billion and quarterly net income of $9 billion. For the same quarter in 2015, these numbers were $51.5 billion and $11.1 billion, repectively. International sales accounted for 62% of the Q4’s revenue ended September 24, 2016. The quarterly results marked the third straight quarter where Apple posted a year-over-year revenue decline.
Novartis saw net profit slip in the third quarter as the loss of a key drug to generic use in the United States outweighed strong sales of its psoriasis drug Cosentyx and MS treatment Gilenya.
Swiss drug company reported third-quarter net income from continuing operations of $1.9 billion, an increase of 7% year-over-year, up more than operating income mainly due to higher income from associated companies.
The new business plan, "signed" by Marco Morelli and approved yesterday by the Board of Directors of MPS, expected net profit of 1.1 billion Euros to 2019. The board of directors scheduled November 24 an extraordinary shareholders’ meeting to approve the capital increase up to a maximum of € 5 billion.
The new business plan then tip a net profit of €1,1 billion in 2019. And at that time also, the MPS plan foresees revenues of 4.5 billion, operating costs to $ 2.46 billion and an operating profit of €1,5 billion. The operating model, the bank explains in a note, it will be renovated and will point to a strong focus on efficiency, with a cost / income ratio of 55% in 2019 and allocated to the commercial activities of a higher proportion of employees from the current 62% to 71%.
For qualified investors / professional clients only
In order to proceed, you must confirm that you are a qualified investor based in Switzerland
The information contained in this section have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document.
Before investing in a product please read the latest prospectus carefully and thoroughly and note that funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided without any guarantee or warranty and are for the recipient's personal use and information purposes only